The US Food and Drug Administration (FDA) has approved Japanese pharmaceutical company Shionogi’s drug Mulpleta (lusutrombopag) indicated for thrombocytopenia in...
Read More...
The post FDA approves Shionogi’s Mulpleta for CLD-associated thrombocytopenia appeared first on Pharmaceutical Technology.
Original Article: FDA approves Shionogi’s Mulpleta for CLD-associated thrombocytopenia